vs
Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and ROGERS CORP (ROG). Click either name above to swap in a different company.
CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $200.5M, roughly 1.2× ROGERS CORP). ROGERS CORP runs the higher net margin — 2.2% vs -35.0%, a 37.3% gap on every dollar of revenue. On growth, ROGERS CORP posted the faster year-over-year revenue change (5.2% vs -23.6%). CROSS COUNTRY HEALTHCARE INC produced more free cash flow last quarter ($16.1M vs $1.1M). Over the past eight quarters, ROGERS CORP's revenue compounded faster (-3.3% CAGR vs -21.0%).
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
Rogers Corporation is a specialty engineered materials company headquartered in Chandler, Arizona.
CCRN vs ROG — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $236.8M | $200.5M |
| Net Profit | $-82.9M | $4.5M |
| Gross Margin | — | 32.2% |
| Operating Margin | -30.2% | — |
| Net Margin | -35.0% | 2.2% |
| Revenue YoY | -23.6% | 5.2% |
| Net Profit YoY | -2109.7% | 421.4% |
| EPS (diluted) | $-2.56 | $0.25 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $200.5M | ||
| Q4 25 | $236.8M | $201.5M | ||
| Q3 25 | $250.1M | $216.0M | ||
| Q2 25 | $274.1M | $202.8M | ||
| Q1 25 | $293.4M | $190.5M | ||
| Q4 24 | $309.9M | $192.2M | ||
| Q3 24 | $315.1M | $210.3M | ||
| Q2 24 | $339.8M | $214.2M |
| Q1 26 | — | $4.5M | ||
| Q4 25 | $-82.9M | $4.6M | ||
| Q3 25 | $-4.8M | $8.6M | ||
| Q2 25 | $-6.7M | $-73.6M | ||
| Q1 25 | $-490.0K | $-1.4M | ||
| Q4 24 | $-3.8M | $-500.0K | ||
| Q3 24 | $2.6M | $10.7M | ||
| Q2 24 | $-16.1M | $8.1M |
| Q1 26 | — | 32.2% | ||
| Q4 25 | — | 31.5% | ||
| Q3 25 | 20.4% | 33.5% | ||
| Q2 25 | 20.4% | 31.6% | ||
| Q1 25 | 20.0% | 29.9% | ||
| Q4 24 | — | 32.1% | ||
| Q3 24 | 20.4% | 35.2% | ||
| Q2 24 | 20.8% | 34.1% |
| Q1 26 | — | — | ||
| Q4 25 | -30.2% | 3.5% | ||
| Q3 25 | -2.4% | 7.3% | ||
| Q2 25 | -2.1% | -33.3% | ||
| Q1 25 | -0.3% | -0.2% | ||
| Q4 24 | -1.1% | -6.6% | ||
| Q3 24 | 0.9% | 6.9% | ||
| Q2 24 | -5.7% | 5.3% |
| Q1 26 | — | 2.2% | ||
| Q4 25 | -35.0% | 2.3% | ||
| Q3 25 | -1.9% | 4.0% | ||
| Q2 25 | -2.4% | -36.3% | ||
| Q1 25 | -0.2% | -0.7% | ||
| Q4 24 | -1.2% | -0.3% | ||
| Q3 24 | 0.8% | 5.1% | ||
| Q2 24 | -4.7% | 3.8% |
| Q1 26 | — | $0.25 | ||
| Q4 25 | $-2.56 | $0.20 | ||
| Q3 25 | $-0.15 | $0.48 | ||
| Q2 25 | $-0.20 | $-4.00 | ||
| Q1 25 | $-0.02 | $-0.08 | ||
| Q4 24 | $-0.13 | $-0.04 | ||
| Q3 24 | $0.08 | $0.58 | ||
| Q2 24 | $-0.47 | $0.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $108.7M | $195.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $322.8M | $1.2B |
| Total Assets | $449.0M | $1.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $195.8M | ||
| Q4 25 | $108.7M | $197.0M | ||
| Q3 25 | $99.1M | $167.8M | ||
| Q2 25 | $81.2M | $157.2M | ||
| Q1 25 | $80.7M | $175.6M | ||
| Q4 24 | $81.6M | $159.8M | ||
| Q3 24 | $64.0M | $146.4M | ||
| Q2 24 | $69.6M | $119.9M |
| Q1 26 | — | $1.2B | ||
| Q4 25 | $322.8M | $1.2B | ||
| Q3 25 | $408.1M | $1.2B | ||
| Q2 25 | $412.2M | $1.2B | ||
| Q1 25 | $418.2M | $1.3B | ||
| Q4 24 | $419.0M | $1.3B | ||
| Q3 24 | $424.7M | $1.3B | ||
| Q2 24 | $433.3M | $1.3B |
| Q1 26 | — | $1.4B | ||
| Q4 25 | $449.0M | $1.4B | ||
| Q3 25 | $538.2M | $1.4B | ||
| Q2 25 | $553.8M | $1.5B | ||
| Q1 25 | $576.2M | $1.5B | ||
| Q4 24 | $589.3M | $1.5B | ||
| Q3 24 | $597.4M | $1.5B | ||
| Q2 24 | $602.9M | $1.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $18.2M | $5.8M |
| Free Cash FlowOCF − Capex | $16.1M | $1.1M |
| FCF MarginFCF / Revenue | 6.8% | 0.5% |
| Capex IntensityCapex / Revenue | 0.9% | 2.3% |
| Cash ConversionOCF / Net Profit | — | 1.29× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $70.1M |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $5.8M | ||
| Q4 25 | $18.2M | $46.9M | ||
| Q3 25 | $20.1M | $28.9M | ||
| Q2 25 | $4.2M | $13.7M | ||
| Q1 25 | $5.7M | $11.7M | ||
| Q4 24 | $24.2M | $33.7M | ||
| Q3 24 | $7.5M | $42.4M | ||
| Q2 24 | $82.4M | $22.9M |
| Q1 26 | — | $1.1M | ||
| Q4 25 | $16.1M | $42.2M | ||
| Q3 25 | $17.9M | $21.2M | ||
| Q2 25 | $2.3M | $5.6M | ||
| Q1 25 | $3.8M | $2.1M | ||
| Q4 24 | $21.7M | $18.3M | ||
| Q3 24 | $6.3M | $25.2M | ||
| Q2 24 | $79.6M | $8.8M |
| Q1 26 | — | 0.5% | ||
| Q4 25 | 6.8% | 20.9% | ||
| Q3 25 | 7.2% | 9.8% | ||
| Q2 25 | 0.8% | 2.8% | ||
| Q1 25 | 1.3% | 1.1% | ||
| Q4 24 | 7.0% | 9.5% | ||
| Q3 24 | 2.0% | 12.0% | ||
| Q2 24 | 23.4% | 4.1% |
| Q1 26 | — | 2.3% | ||
| Q4 25 | 0.9% | 2.3% | ||
| Q3 25 | 0.9% | 3.6% | ||
| Q2 25 | 0.7% | 4.0% | ||
| Q1 25 | 0.6% | 5.0% | ||
| Q4 24 | 0.8% | 8.0% | ||
| Q3 24 | 0.4% | 8.2% | ||
| Q2 24 | 0.8% | 6.6% |
| Q1 26 | — | 1.29× | ||
| Q4 25 | — | 10.20× | ||
| Q3 25 | — | 3.36× | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.92× | 3.96× | ||
| Q2 24 | — | 2.83× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CCRN
| Temporary Staffing Services | $189.6M | 80% |
| Physician Staffing | $42.5M | 18% |
| Other Services | $4.7M | 2% |
ROG
Segment breakdown not available.
